Skip to main content
. 2016 May 13;3(3):181–189. doi: 10.1093/jhps/hnw015

Table I.

All included studies

Study Type Group 1 N Group 2 N Outcomes
Morgenthaler et al. [15] RCT Intra-articular bupivacaine 13 Placebo 13 VAS and rescue medication
Baker et al. [16] RCT Portal infiltration 33 Intra-articular infiltration 40 VAS and rescue medication
Ward et al. [6] RCT Femoral nerve block 20 General anesthesia 20 PACU time, nausea, operation time
YaDeau et al. [17] RCT Lumbar plexus nerve block 41 General anesthesia 41 VAS, rescue medication, nausea/vomiting, hospital stay
Zhang et al. [8] RCT 200mg Celecoxib 27 Placebo 26 VAS and rescue medication
Krych et al. [18] Prospective series Fascia iliaca block 30 No control group VAS, nausea, opioid use, patient satisfaction
Potter et al. [19] Prospective series Fascia iliaca block 53 General anesthesia 54 VAS, PACU time, opioid use
Dold et al. [20] Retrospective review Femoral nerve block 56 General anesthesia 40 VAS, PACU time, opioid use
Baker et al. 2011 [11] Retrospective chart review Bupivacaine intra-articular 85 No control group VAS, opiate requirement
Schroeder et al. [21] Retrospective review Lumbar plexus block 118 General anesthesia 118 Peak PACU pain, PACU time, escape medication